AZD2171
Drug timelines are a Plus or Pro feature.
17 regulatory and trial events tracked for AZD2171, covering 2009-05-14 to 2017-01-31. Get the full timeline:
Most recent: Clinical Trial Update: Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]